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Abstract
Background: The specific genetic regulation of neural primordial cell determination is of great interest in stem cell
biology. The Musashi1 (Msi1) protein, which belongs to an evolutionarily conserved family of RNA-binding proteins,
is a marker for neural stem/progenitor cells (NS/PCs) in the embryonic and post-natal central nervous system (CNS).
Msi1 regulates the translation of its downstream targets, including m-Numb and p21 mRNAs. In vitro experiments
using knockout mice have shown that Msi1 and its isoform Musashi2 (Msi2) keep NS/PCs in an undifferentiated
and proliferative state. Msi1 is expressed not only in NS/PCs, but also in other somatic stem cells and in tumours.
Based on previous findings, Msi1 is likely to be a key regulator for maintaining the characteristics of self-renewing
stem cells. However, the mechanisms regulating Msi1 expression are not yet clear.
Results: To identify the DNA region affecting Msi1 transcription, we inserted the fusion gene ffLuc, comprised of
the fluorescent Venus protein and firefly Luciferase, at the translation initiation site of the mouse Msi1 gene locus
contained in a 184-kb bacterial artificial chromosome (BAC). Fluorescence and Luciferase activity, reflecting the Msi1
transcriptional activity, were observed in a stable BAC-carrying embryonic stem cell line when it was induced
toward neural lineage differentiation by retinoic acid treatment. When neuronal differentiation was induced in
embryoid body (EB)-derived neurosphere cells, reporter signals were detected in Msi1-positive NSCs and GFAP-
positive astrocytes, but not in MAP2-positive neurons. By introducing deletions into the BAC reporter gene and
conducting further reporter experiments using a minimized enhancer region, we identified a region, “D5E2,” that is
responsible for Msi1 transcription in NS/PCs.
Conclusions: A regulatory element for Msi1 transcription in NS/PCs is located in the sixth intron of the Msi1 gene.
The 595-bp D5E2 intronic enhancer can transactivate Msi1 gene expression with cell-type specificity markedly
similar to the endogenous Msi1 expression patterns.
Background
Neural stem cells (NSCs) are one of the most important
research targets in developmental neurobiology, and are
attracting attention in strategies for central nervous sys-
tem (CNS) regeneration [1-6]. NSCs are somatic stem
cells that exist in both the embryonic and adult CNS,
and they can be defined conceptually as cells that pos-
sess both multipotency and the ability for self-renewal
[1,2]. Selective NSC markers include the intermediate
filament protein Nestin and the RNA-binding protein
Musashi1 (Msi1) [7,8]. In the mammalian embryonic
CNS, neural stem/progenitor cells (NS/PCs), which
include NSCs and neural precursor cells, are present in
the ventricular zone of the developing neural tube.
Immunoreactivity against Nestin and Msi1 are consis-
tently detected in the ventricular zone [7-9].
The Musashi family of RNA-binding proteins [10,11]
is evolutionarily conserved. Two members, Msi1 and
Msi2, have been identified in mammals [8,10,12].
Furthermore, the expression pattern of Msi1 was inves-
tigated using a specific monoclonal antibody against
Msi1 [9]. Msi1 is downregulated in post-mitotic neurons
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believed to contribute to maintaining the stemness of
NS/PCs in the embryonic and post-natal stages through
the translational regulation of its target mRNAs, which
are involved in regulating cell fates and the cell cycle
[10,11,13]. We have identified Musashi-binding RNA
sequences in mammals [14] and Drosophila [15]. Our
previous studies revealed that Msi1 contributes to NS/
PC maintenance by binding to the 3’-untranslated
region (UTR) of m-numb mRNA, an Msi1 target, and
repressing its translation [14]. The m-numb mRNA
encodes a membrane-associated protein that inhibits
Notch signalling [16]. Other Msi1 target mRNAs and
regulatory pathways have also been reported [17-19].
Interestingly, some groups have reported that high Msi1
expression potentiates Notch signalling or causes cell-
cycle progression in certain tumour cells [20-22]. Simi-
larly, Msi1 is known to be associated with various kinds
of tumours, including glioblastoma, hepatoma, and
intestinal tumours [23-25].
Recently, mammalian Msi1 protein was identified not
only in the CNS, but also in other tissues and organs.
Intriguingly, Msi1 has been detected in somatic stem
cells in adult tissues, including the eye [26], intestine
[27], stomach [28], mammary gland [29], hair follicle
[30], and germ-line tissue [31]. Thus, Msi1 may contri-
bute to maintaining the stem cell state by controlling
the translation of downstream target genes. To better
understand Msi1’s spatial and temporal distribution in
NSCs, we sought to identify the genome region involved
in Msi1 gene transcription. Furthermore, the identifica-
tion of this region may lead to putative transcription
factors involved in regulating Msi1’s expression.
Relationships between stem cells and transcription fac-
tors in the CNS have been intensively investigated
[32,33]. For example, members of the SOX (Sry like
HMG box protein) family are known to be transcription
factors that define characteristics of stem cells, including
NSCs [34]. SOX2 is expressed in embryonic stem cells
(ESCs), and both SOX1 and SOX2 are expressed in NS/
PCs after neural induction [35]. SOX proteins are
known to be involved in the transcriptional activation of
the Nestin gene. The Nestin NSC-specific transcription
enhancer is present in its second intron and contains
binding sites for SOX and POU (Pit-Oct-Unc)[36,37].
The POU family was originally defined as transcription
factors containing a common region called a POU
domain. Oct4, a member of the POU family, plays a
role in regulating Sox2 in inner-cell-mass ESCs and dur-
ing their transition to neural cells, before the recruit-
ment of neural POU factors such as Brn1 and Brn2
[36-38]. Indeed, SOX2 and Brn2 cooperatively transacti-
vate Nestin gene transcription through the second
intron enhancer [39]. While the mechanism of Nestin
transcription has been clarified, those of other NSC
markers, including the Msi1 gene, remain unclear.
There has been tremendous innovation in the last
decade in scientific engineering techniques, materials,
and knowledge databases, including genome sequence
databases. In particular, the science of genome informa-
tion has progressed not only in regard to nucleotide
sequence information, but also in the procedures for
analyzing chromatin modification and transcription-fac-
tor binding. The development and dissemination of bac-
terial artificial chromosomes (BAC) enables the use of
genomic DNA, including large areas that can cover the
whole locus of a gene [40-43]. Engineering techniques
such as DNA recombination methods have also been
improved. Fluorescent protein reporter genes have been
developed and improved [44-47]. Taking advantage of
these tools, we constructed a recombinant BAC reporter
to analyze the molecular mechanism of Msi1 transcrip-
tion regulation. We used a homologous recombination
technique to insert the newly generated reporter gene
ffLuc near the Msi1 transcription start site (TSS). Using
this reporter-containing BAC, which we designated
Msi1-ffLuc,w ew e r ea b l et oa n a l y z ew h e r eMsi1 tran-
scription is activated. Through these investigations, we
have identified a new Msi1 transcription enhancer ele-
ment in NS/PCs. This region is located in the 595-bp
region within the sixth intron of the Msi1 gene, and
contains SOX- and AP-2-binding sites.
Results
Generation of an Msi1-transcription reporter BAC bearing
a 184-kb Msi1 genomic region
To identify transcription or signalling pathway-asso-
ciated factors involved in regulating Msi1 gene tran-
scription, we generated a BAC reporter gene to detect
Msi1 transcriptional activity in NS/PCs. We previously
reported generating an Msi1 transcription reporter gene
that contained an approximately 3-kb 5’ upstream
region of the mouse Msi1 TSS, which, through
unknown mechanisms, could act in human cells but not
in mouse cells [48]. To elucidate Msi1 transcriptional
regulatory mechanisms in vivo more precisely, we pre-
pared the RP24-132L16 BAC as a genomic element con-
taining many of the cis-elements that direct Msi1
transcription. As shown in Figure 1A, the RP24-132L16
BAC contains 133-kb of the 5’ region upstream of the
Msi1 TSS, the Msi1 mRNA coding region (exons-
introns coding region), and 29-kb of the 3’ region down-
stream of the 3’-end of the Msi1 gene. We then used
homologous recombination techniques to insert the
ffLuc reporter gene into the Msi1 translational initiation
site of the RP24-132L16 BAC (Figure 1A). The ffLuc
reporter gene encodes a fusion protein of the fluores-
cent protein Venus and firefly Luciferase [45,46]. This
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Page 2 of 16Figure 1 The 184-kb Msi1-reporter expression corresponds to endogenous Msi1 expressed in NS/PCs in vivo. (A) The original BAC (RP24-
132L16) and the position of Msi1 are shown. There was a 22-kb region of Msi1 exons and introns between the 133-kb 5’ upstream and 29-kb 3’
downstream regions of Msi1. The translation initiation codon (ATG) was replaced with ffLuc to produce Msi1-ffLuc. (B) GFP in the E12.5 transgenic
mouse containing Msi1-ffLuc, was expressed in the central nervous system and eye (upper panel: bright-field image, lower panel: fluorescent
image). (C) Immunohistochemical analysis in the E14.5 Tg mouse cortex. Msi1, Group B1 SOX [SOX1/(2)/3], and Nestin expression in
undifferentiated cells in the ventricular zone co-localized with GFP expression (Scale bar: 50 μm). The images shown in the small boxes in the
right column panels are magnified and shown in the left corner boxes (Scale bar in magnified image: 10 μm). GFP was also present in the
ventricular zone of the midbrain (D), pontine area (E), and eye (F). An arrow shows expression of GFP in retinal ganglion cell layer and an
arrowhead shows expression of GFP in lens. AQ: aqueduct of midbrain, V4: fourth ventricle. Scale bar: 100 μm.
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Page 3 of 16reporter gene both visualized Msi1 transcriptional activ-
ity in vivo, and allowed us to use Luciferase biolumines-
cence to quantify the level of transcriptional activity.
Generation of Msi1-transcription reporter BAC tg mice
and recombinant ES cell lines
To determine how well the Msi1 B A Cr e p o r t e rg e n e
expression reflected endogenous Msi1 protein expres-
sion in vivo both spatially and temporally, we generated
Msi1 BAC reporter transgenic (tg) mice. GFP fluores-
cence was observed in the CNS of embryonic day (E)
12.5 Msi1 reporter tg mice, while it was not detected in
wildtype littermates (Figure 1B). For the rest of this arti-
cle, we will describe Venus fluorescence as GFP fluores-
cence, and Venus expression immunodetected with anti-
GFP antibody as GFP expression. We next used immu-
nohistochemistry to analyze the distributions of GFP,
Msi1, Group B1 SOX, and the intermediate filament
protein Nestin in the cerebral cortex of E14.5 mice. We
observed that GFP was expressed in the ventricular
zone, where proliferative NS/PCs are present (Figure
1C, D, E). GFP was also expressed in the retinal gang-
lion cell layer, neuroblastic layer and lens in the devel-
oping eye (Figure 1 F). GFP expression co-localized with
endogenous Msi1, Group B1 SOX, and Nestin (Figure
1C). GFP expression was also observed in the subventri-
cular and subgranular zones of the adult mouse brain,
where it co-localized with endogenous Msi1 (Additional
file 1, Figure S1). Based on these observations, we con-
cluded that the Msi1 BAC reporter can reflect endogen-
ous Msi1 expression in the CNS in vivo.
We next examined how well the BAC reporter signal
corresponds to endogenous Msi1 expression during the
neural differentiation of ESCs. For this purpose, we gen-
erated ESC lines with stably-integrated Msi1 BAC DNA.
We introduced Msi1 BAC DNA into parent (line EB3
tg14) ESCs. Forty-seven stable lines were established
and characterized by their neural differentiation, using
the scheme shown in Figure 2A. ESCs can be induced
into neural lineages, including NSCs, by treatment with
retinoic acid (RA) at a low concentration (10
-8M). In
embryoid body (EB)-forming cells, NS/PCs expressing
Msi1 and/or Nestin can be efficiently induced by treat-
ment with 10
-8M RA [49]. We cultured recombinant
ESCs in floating conditions to form EBs, added 10
-8M
RA to the culture medium after 2 days to induce neural
differentiation, and cultured the cells for 4 more days
(Figure 2A). Recombinant ES clones bearing Msi1 BAC
DNA frequently showed GFP fluorescence on EB day 6
with RA (+RA), while GFP was not expressed in ESCs
and RA-untreated EBs(-RA) (Figure 2B left panel). Fire-
fly Luciferase activity, reflecting the Msi1 transcription
activity, was measured in EBs treated with RA and with-
out RA. The average luminescent activity per total
protein increased about 10-fold in the treated EBs
(+RA) over that found in undifferentiated recombinant
ESCs (Figure 2B right panel). Luciferase activity in trea-
ted EBs (+RA) was about 5-fold greater than in
untreated EBs (-RA) (Figure 2B right panel).
To determine whether the GFP fluorescence corre-
lated with Msi1 mRNA levels, we determined the Msi1
mRNA levels in three cell populations (H, M, and L).
To form these populations, we dissociated EB cell aggre-
gates derived from representative recombinant ES lines,
and separated them by cell sorter based on their fluores-
cence intensity (H > M > L) (Figure 2C, left panel). As
we expected, the GFP mRNA level, as measured by
quantitative RT-PCR, was in proportion to the GFP
fluorescence, and the Msi1 and Nestin mRNA levels
were also in proportion to the GFP fluorescence (Figure
2C, right panel). Taken together, these findings show
that the Msi1 mRNA level increased during induced dif-
ferentiation toward NSCs, as reflected in the Luciferase
activity, and that the Msi1 mRNA level correlated with
the intensity of GFP fluorescence. In addition, we used
flow cytometric analysis to examine whether the GFP
and Msi1 levels were correlated. Of all the EB (+RA)
cells, 89% were positive for Msi1, and 80.5% were posi-
tive for both GFP and Msi1 (Additional file 2, Figure
S2), indicating that the GFP expression correlated well
with the Msi1 expression.
Next, we characterized the cell-type specificity of the
GFP-expressing cells by immunochemical analysis. After
4 days in RA-treated culture, the EBs were dissociated
and placed in floating culture conditions in the presence
of FGF-2 and EGF; primary neurospheres formed after 6
days of culture (Figure 2A). The primary neurospheres
were dissociated, and secondary neurospheres were sub-
sequently generated in the same culture conditions for
an additional 6 days. The secondary neurospheres were
then dissociated and induced into neuronal and glial dif-
ferentiation in an attached condition, without FGF-2 or
EGF. After 4 days in differentiation culture, few cells
expressing the post-mitotic neuronal marker protein
MAP2 demonstrated immunoreactivity against GFP.
However, Msi1 and Nestin were co-localized with GFP
(Figure 2D).
We quantified the overlap of Msi1 with GFP and with
differentiation markers by using high-throughput analyz-
ing microscopy with the In Cell Analyzer 2000 (GE
Healthcare Biosciences). We observed that cells expres-
sing GFAP, Nestin, and bIII-Tubulin corresponded to
43%, 56%, and 33% of the endogenous Msi1-expressing
cells and that Msi1 expression level was weak in bIII-
Tubulin-positive cells (Figure 2E upper left panel). Some
of cells were positive for both Msi1 and GFAP or bIII-
Tubulin. These observations are consistent with pre-
v i o u sf i n d i n g st h a tM s i 1i se x p r e s s e di nG F A P - p o s i t i v e
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Page 4 of 16Figure 2 Msi1-ffLuc expression corresponds with Msi1-positive NS/PCs and astrocytes in Msi1-ffLuc ESC-derived neural cells. (A) The
experimental protocol for embryonic stem cell (ESC) differentiation with a retinoic-acid (RA) conditioned medium. ESCs formed embryoid bodies
(EB) after 6 days in floating culture. (B) The expression of Msi1-ffLuc on day 0 of ESCs and day 6 of EBs is shown in the left panels. GFP was not
expressed in ESCs and RA-untreated EBs(-RA) but was expressed in RA-treated EB(+RA). Nine Msi1-ffLuc ES cell lines were analysed for GFP
fluorescence in each condition indicated (right panel). Scale bar: 100 μm. FLU: firefly luciferase light unit. (C) Dissociated day-6 EBs (+RA) derived
from Msi1-ffLuc ES cell line (Red line in left panel) were assessed by flow cytometry and divided into H, M, and L fractions according to their GFP
intensity. Each fraction was then analysed by qRT-PCR. The GFP, Msi1, and Nestin mRNA transcripts were enriched in the H fraction (L = 1 in
each fraction). Black line in left panel shows day-6 EBs (+RA) derived from wild type ES cell line. (D), (E) secondary neurospheres were
dissociated, cultured in differentiation medium for 4 days, and immunostained. Anti-GFP reactivity for GFP(+) cells correlated with Nestin(+) and
endogenous Msi1(+) cells, but not with MAP2(+) mature neurons with long processes (D, Scale bar: 50 um). Vertical arrowheads show Marker
(+)/GFP(+) cells. The immunofluorescent intensity of each marker was represented by scatter blots (E). The vertical axis shows the intensity of
Msi1 and of cell-type-specific markers for neurons (b-III Tubulin), astrocytes (GFAP) and NS/PCs (Nestin). The horizontal axis shows the
endogenous Msi1 (upper panel) and GFP (lower panel) intensities. The proportion (%) of marker(+) cells among GFP(+) cells is indicated in the
bottom of each box. Note that the GFP/Marker double-positive cells were highly observed for Msi1, GFAP, and Nestin, but the b-III Tubulin-
positive neurons had weak GFP expression.
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Page 5 of 16astrocytes, and that low levels of Msi1 are observed in
young, immature neurons [9,12]. Significantly, cells
expressing Msi1, GFAP, Nestin, and bIII-Tubulin corre-
sponded to 92%, 44%, 51%, and 35% of the GFP-expres-
sing cells, similar to endogenous Msi1 positive cells
(Figure 2E lower panel). It is especially noteworthy that
Msi1(+) cells correlated well with GFP(+) cells (Figure
2E lower panel). Thus, Msi1-expressing cells correlated
well with GFP-expressing cells in a neural differentiation
system using ESCs bearing the Msi1 BAC reporter.
Deletion study of the Msi1 BAC reporter to identify cis-
elements involved in Msi1 gene transcription
To elucidate the regulatory mechanisms of Msi1 gene
transcription, we performed a deletion study to deter-
mine whether there are cis-elements in the 184-kb
region of genomic DNA containing the Msi1 loci that
are sufficient for inducing Msi1 transcription. Accord-
ingly, a module containing the neomycin-resistance gene
was inserted into the Msi1 5’-upstream region and the
exon-intron coding region (D1-D5). The BAC constructs
were generated by homologous recombination, as shown
in Figure 3A and 3B. The length and location of the
deleted regions were designed by considering evolutio-
narily conserved regions among species–mouse, human,
horse, rat, and chicken. This homology alignment was
performed with the VISTA homology search program
[50]. It was also taken into consideration that the adja-
cent genes Cox6A1 and Pla2G1b are located 80-kb
upstream and 54-kb downstream of the Msi1 TSS,
respectively (Figure 3B).
The deleted BAC constructs were introduced into
ESCs, and stable transformants were established for
each BAC reporter construct. In a similar manner to the
RA treatment and Luciferase reporter assay conducted
with EBs (shown in Figure 2A), the Msi1 transcriptional
activities were quantified using the deletion-containing
reporters D1-D5 and the full-length BAC reporter D0.
The Luciferase activity was measured by normalization
with CellTiter-Blue [Promega], which was used for a live
cell count. The gene expression level of 21 clones for
each deletion or the full-length transformant showed
that the Luciferase activity was lower in EBs bearing the
D2-D4 deletion reporter genes than in those bearing the
D1 or the full-length D0 reporter genes (Figure 3C).
These results suggested that the 10-kb region from 55
kb to 65 kb upstream of the TSS might contain Msi1
transcriptional enhancers, and we named this region the
‘upstream 10-kb enhancer.’ Furthermore, when the
region after the transcription site (exons and introns
coding region) was deleted, the Msi1 transcriptional
activity diminished even in the presence of the
‘upstream 10-kb enhancer’ (Figure 3C). These results
indicated two regions responsible for Msi1 transcription.
However, the exon-intron coding region is likely to be
primarily necessary for Msi1 transcription.
To find the region responsible for Msi1 transcription,
we performed a genome informatics database search.
The UCSC Genome Browser on Mouse Feb. 2006
(NCBI36/mm8) Assembly showed that there were
approximately three notable H3K4me1 ChIP-sequence
tags in the 184-kb BAC-contained region, using neural
progenitor cells as material (Additional file 3, Figure
S3). The regions corresponding to the three tags are
labelled as D2E, D3E and D5E2 in Figure 3B and Addi-
tional file 3, Figure S3. Monomethylation, but not tri-
methylation, of lysine 4 of histone H3 is known as an
active enhancer [51]. These three regions were also CpG
islands, which indicates that they may be developmen-
tally regulated regions. The first region, designated D2E,
was in the upstream 10-kb enhancer region (Figure 3B)
and was highly homologous among the five indicated
species. The second region was located 31-kb upstream
of the TSS, and we designated this as D3E (Figure 3B).
The third region was located 7.3-kb downstream from
the TSS, which is included in the sixth intron, and we
designated this as D5E2 (Figure 3B). Interestingly, D3E
and D5E2 were also identified as p300-binding regions
in the embryonic forebrain [52,53]. The transcriptional
coactivator protein p300 is expressed almost ubiqui-
tously in mouse embryogenesis, and can bind to a wide
spectrum of active tissue-specific enhancers. D3E is also
a highly homologous region among the mouse, human,
horse, rat, and chicken genes. D5E2 exhibits high
homology among four of the species, but not with
chicken. Of these three regions that could be responsi-
ble for Msi1’s transcriptional enhancement, the results
of our Msi1 BAC deletion study (Figure 3) and previous
bioinformation studies led us to analyze the enhancer
function of two of them, D2E and D5E2, in more detail
in NS/PCs.
Minimized reporter assays in NS/PCs revealed that D5E2
was competent to control Msi1 transcription specificity
To investigate whether D2E and D5E2 function as loca-
lized enhancer regions to regulate Msi1 transcription,
we generated constructs containing a minimal enhancer
(D2E, D5E2, or none), the P1 promoter 1-kb upstream
of the Msi1 TSS, and ffLuc (Figure 4A). With the origi-
nal locations on the genome in mind, D2E was placed at
the 5’-end of the P1 promoter, and D5E2 was placed at
the 3’-end of the ffLuc-SV40 poly(A) additional signal
element (Figure 4A). D5E1, which was included in the
fourth intron and was well-conserved in the mouse,
human, horse, and rat species (but not chicken), was
not included in the p300 ChIP-sequence tags, and was
used as a negative control [53] (Figure 3B). The Nestin-
TKp construct contained a rat Nestin second intron
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Page 6 of 16Figure 3 Msi1 BAC deletion studies suggest that both the 55-65 kb 5’ upstream region and the exon-intron coding region have Msi1
transcriptional activity. (A) Schematic representation of our deletion method. Targeted Msi1 enhancer/promoter regions were replaced with
pgk pro.-Neo
r-bGH pA to select for successfully recombined clones. (B) The conserved genomic region between cox6a1 and pla2g1b in Msi1-ffLuc
is shown. VISTA plots comparing the alignment of mouse versus human, horse, rat, and chicken. Full-length Msi1-ffLuc (D0) and deletion
constructs (D1-D5) are also indicated. Blanks represent deleted regions replaced with pgk pro.-Neo
r-bGH pA. The positions of candidate enhancer
sites used in later experiments are also shown (see details in Results). The exon-intron coding region of Msi1 gene is magnified. Red circles
indicate candidate enhancer sites, white boxes indicate exons. (C) Gene expression in EBs derived from the deletion-reporter ES cell lines. All 21
cell lines were analysed for Luciferase expression in +RA neural induction cultures for 6 days (blue bars). Clones are presented in rank order for
neural cultures. The red bars show the activity in the same clone under non-neural inducing conditions (-RA, not in rank order). Luciferase
activity was normalized to the cell-viability fluorescence intensity using CellTiter-Blue (CTBF). The Msi1 expression in D0 and D1 was greatly
increased under the neural-inducing conditions. Note that D5 showed decreased Msi1 expression; D2-D4, which included a 55-65-kb deletion,
showed an even greater decrease.
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Page 7 of 16Figure 4 D5E2 is a transcriptional enhancer that functions in NS/PCs. Candidate enhancer alignments were selected using information from
the UCSC genome data base and by looking at p300-binding sites [52,53] in the expected enhancer regions of introns and 55-65 Kb upstream.
Each enhancer reporter gene used in the experiments is shown in (A). Nestin second intron-Tkp was used as a positive control. (B), (C) Candidate
enhancer activities in ESCs and NS/PCs. Dissociated E14.5 cortex cells were cultured on a poly-D-Ornithine/fibronectin coated dish in an FGF-2/
EGF mixed selective NS/PC conditioned medium. Enhancer reporter constructs were transfected into EB3 tg14 and NS/PCs, and the Luciferase
activity was detected after 48 hours. The D2E and D5E2 sites enhanced the transcriptional activity in ESCs, and the D5E2 site enhanced it in NS/
PCs [4.3-fold, 5.1-fold in ESCs, 2.2-fold, 15.2-fold in NS/PCs, respectively, compared with P1 (P1 = 1)], but D5E1 could not enhance the activity in
either cell type. The data represent the mean ±SEM of three independent experiments. The data were subjected to non-repeated-measures
ANOVA tests, and p values were calculated by Bonferroni multiple comparison tests. *p < 0.05: P1 to D2E-P1, D5E1-P1, or D5E2-P1, ns: not
significant. FLU/RLU: firefly luciferase light unit/renilla luciferase light unit. (D), (E) The D2E and D5E2 enhancer activities were confirmed in EBs:
47 stable ES cell lines for P1, D2E-P1, and D5E2-P1were established and cultured in EB-formation conditions with or without RA. (D) Day 6 of
neural-induced EB (+RA). Left panel shows bright field and right panel shows fluorescent images. Scale bar: 100 μm. (E) All cell lines were
analysed for each condition on day 6. Average intensity is shown in comparison to RA-treated P1 (P1: +RA = 1, -RA = 0.33, D2E-P1: +RA = 3.47,
-RA = 0.26, D5E2-P1: +RA = 16.7, -RA = 3.18.). Note that D5E2-P1 showed potent enhancer activity in the neural induced EBs.
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promoter element, and ffLuc.T h i sNestin enhancer is
known to induce transcriptional activity in NS/PCs
[35,54]. These constructs were transiently introduced
with an internal control Renilla luciferase-expressing
plasmid into ESCs or NS/PCs derived from the mouse
brain cortex at E14.5 and cultured in the presence of
FGF-2 and EGF. The transfected cells were lysed after 2
days in culture, and their Luciferase activity was mea-
sured. The Luciferase activity was low in ESCs or NS/
PCs with the D5E1-P1 construct or with only the P1-
promoter construct. We also observed weak Luciferase
activity in ESCs with D2E-P1 or D5E2-P1; reporter sig-
nals in these ESCs showed 4-5-fold increases compared
to the signals in cells with only the P1 construct. Inter-
estingly, the Luciferase activity in NS/PCs with a trans-
fected D5E2-P1 construct increased markedly, 15.2-fold,
compared with the signals of cells with the P1 construct.
When D2E-P1 was introduced into NS/PCs, a 2.2-fold
increase in the reporter signal was observed compared
to P1 alone, however, there were no stastical difference
between them. These findings together indicated that
D5E2 can work efficiently as an Msi1 transcription
enhancer in terms of the strength and specificity of
transactivation in NS/PCs.
We next generated recombinant, stable ES lines con-
taining each of the constructs P1, D2E-P1 and D5E2-P1
to determine whether the D5E2 enhancer has cell-type
specificity and transactivation intensity during neuronal
and glial differentiation. RA was added to the medium
at 10
-8M concentration 2 days after starting floating EB
culture. After an additional 6 days, GFP fluorescent and
f i r e f l yL u c i f e r a s ea c t i v i t yw e r ef r e q u e n t l yo b s e r v e di n
EBs (+RA) derived from ES clones containing the D5E2-
P1 construct (Figure 4E). There was no detectable GFP
fluorescence or firefly Luciferase activity in the EBs
(+RA) derived from ES clones containing the P1 con-
struct (Figure 4E). The GFP expression and Luciferase
activity were less intense in the D2E-P1-bearing EBs
(+RA) than in the D5E2-P1-bearing EBs; P1 = 1, D2E-
P1 (+RA) = 3.4, D5E2-P1 (+RA) = 16.7 (Figure 4D, E).
These results indicated that D2E and D5E2 are capable
of transactivation in NS/PCs derived from EB (+RA)
cells. The transactivation intensity of the D5E2 enhancer
was higher than that of the D2E enhancer in NS/PCs,
similar to our findings in cultured NS/PCs derived from
the mouse embryonic cortex.
D5E2 is an authentic enhancer that reflects Msi1
transcription activity and directs cell-type-specific
transactivation during neurogenesis and gliogenesis
We next examined whether the activities of the mini-
mized Msi1 transcriptional enhancers corresponded
with endogenous Msi1 expression, which was high in
NS/PCs and astrocytes and low in the neuronal linage.
For this purpose, EB (+RA)s were taken from the three
cell lines showing the most intense Venus expression
for each integrated construct (P1-, D2E-P1- and D5E2-
P1-integrated EBs) and placed in floating culture for 6
days to form primary neurospheres (Figure 4). GFP-
fluorescence was detected in primary neurospheres con-
taining the D5E2 construct (Figure 5A). Primary spheres
containing P1, D2E-P1, or D5E2-P1 were also subjected
to Luciferase assays. The Luciferase activity was 18.2-
fold stronger in the primary neurospheres with D5E2-P1
than in those with P1 alone (Figure 5B), and 1.4-fold
greater in the primary neurospheres with D2E-P1 than
in those with P1 alone (Figure 5B).
Next, the secondary neurospheres containing minimal
reporter genes were dissociated, and the cells were cul-
tured for neuronal and glial differentiation in the same
conditions as in the experiment shown in Figure 2A.
After 4 days of differentiation culture, the cells were
fixed and immunostained with anti-GFP, anti-Msi1,
anti-bIII-Tubulin, anti-GFAP, and anti-Nestin antibo-
dies. GFP expression was found in the cells with D5E2-
P1, but not in those with P1 alone (Figure 5C). We then
quantified the rates of cells positive for Msi1 or other
differentiation markers in the GFP(+) population using
an In Cell Analyzer 2000. The proportions of GFP(+)
cells expressing Msi1, GFAP, Nestin, and bIII-Tubulin
were 94%, 37%, 50%, and 34%, respectively (Figure 5D).
Notably, the specificity of the reporter signal displayed
by the full-length BAC reporter (Msi1-ffLuc)w a sv e r y
similar to that of the D5E2-containing reporter. Taking
all these results together, we concluded that we had
identified one of the regions responsible for Msi1’s tran-
scriptional activation: our findings indicate that Msi1
transcriptional activity is conserved in 595 bp of the
D5E2 region in the sixth intron.
Discussion
In this study, we generated the reporter gene Msi1-ffLuc,
which has Msi1 gene locus contained in a 184 kb BAC,
and confirmed that this reporter accurately reflected
endogenous Msi1 expression in the CNS of transgenic
mice and in ES-derived neural cells. This reporter
m a k e si tp o s s i b l et od e t e c tM si1 expression by fluores-
cence and luminescence. The proportion of cells expres-
sing the markers bIII-Tubulin, GFAP, and Nestin in the
GFP(+) population correlated well with those among
Msi1(+) cells in differentiated EB-derived neural cells,
and the fluorescence distribution approximated that for
each marker (Figure 2D, E). While almost all the GFP
(+) cells were positive for Msi1, strong GFP expression
was not observed in MAP2(+) mature neurons. Notably,
35% of the GFP(+) cells (33% of the endogenous Msi1
(+) cells) were bIII-Tubulin(+) young neurons. However,
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Page 9 of 16Figure 5 D5E2-P1 expression corresponds with Msi1-positive NS/PCs and astrocytes. (A), (B) D5E2-P1 was active in primary neurospheres.
(A) Primary neurospheres derived from ESC lines, on day 6. Scale bar: 100 μm. (B) Three cell lines with intense reporter expression were selected
from 47 ES cell lines; EB(+RA) were selected and primary neurospheres were formed in each clone. The reporter activity was analysed on day 6.
(C) Cells from secondary neurospheres were differentiated and stained with each antibody shown. D5E2-P1 showed intense GFP expression. GFP
was not induced by P1, and was only slightly induced by D2E-P1. Vertical arrowheads show Marker(+)/GFP(+) cells. D5E2-P1 induced GFP
expression in Msi1(+) and Nestin(+)/GFAP(+) cells. Scale bar: 50 um. (D) Immunofluorescence intensity was visualized by scatter plots. The vertical
axis shows the intensity of Msi1 and each cell-type-specific marker. The horizontal axis shows GFP intensity. The ratio of marker(+) GFP(+)/GFP(+)
(%) cells is indicated at the bottom of the boxes.
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Page 10 of 16the fluorescent intensity of GFP or Msi1 in the young
neurons was much weaker than that in GFAP-, Nestin-,
and Msi1-positive cells. These findings corresponded
with the endogenous Msi1 expression reported pre-
viously; Msi1 expression is strongly detected in 30-40%
of the cells with the Ta1 promoter driving reporter
expression, and weakly expressed in bIII-Tubulin(+) or
MAP2(+) post-mitotic neurons [9]. We previously found
that Msi1 is not detected in mature neurons with long,
thick processes; GFP fluorescence was not observed in
these cells in the present study either, suggesting that
neuronal maturation correlates with a downregulated
reporter signal; this is consistent with another report
using a Nestin second intron-EGFP mouse [54]. GFP-
expressing cells were widely present in the ventricular
zone through the caudal-rostral axis in the embryonic
stage, and were restricted to the subventricular zone
and subgranular zone, and to GFAP-positive astrocytes
in adult mice. This is similar to Msi1 expression in the
adult mouse, and the spatio-temporal regulation is the
same as in our findings (Figure 1, Additional file 1, Fig-
ure S1) [8,55]. These results indicate that the Msi1-ffLuc
reporter expression accurately mimics endogenous Msi1
expression, and that this 184-kb genomic region is suffi-
cient to activate Msi1 transcription.
We found two regions that increased the Msi1 tran-
scriptional activity, in what we designated the “upstream
10-kb enhancer” (55-65 kb region upstream of the TSS)
and in the Msi1 exon-intron coding region. Luciferase
assays of deletion constructs in the absence of each
region showed significant Luciferase reduction in EBs
(+RA); in particular, almost all the Luciferase activity
was diminished in D5. This result indicated that the
exon-intron coding region includes requisite enhancer
sites. Intense activity through D5E2 enhancer, which is
included in sixth intron, supported this conclusion. The
upstream 10-kb enhancer site was also an active enhan-
cer region in NS/PCs, although the expression level was
low. We prepared a 10-kb enhancer-P1 reporter gene
and detected the Luciferase activity in NS/PCs derived
from the E14.5 mouse cerebral cortex. A 3.7-fold
enhancement was observed over using a reporter gene
with P1 alone (data not shown). This increase is subtle
compared to the 15.2-fold enhancement seen with
D5E2, and the just-over-2.2-fold enhancement with
D2E. D2E is one of the most highly evolutionarily con-
served sites in the upstream 10-kb enhancer region; no
other highly conserved site could be found in this area.
D2E was most active in ESCs (4.3-fold), with less activity
in EBs(+RA) (3.4-fold) or primary neurospheres (1.39-
fold), with the direction of neural lineage. Consistent
with our results, p300 does not bind to D2E in either
the forebrain or midbrain, while it binds strongly
to D5E2 in both regions [52,53]. EBs consist of
heterogeneous cell populations even when induced
under 10
-8 M RA; that is, endodermal cells, mesodermal
cells, and ectodermal cells are all present [49]. Msi1-
positive cells are found in the intestine, stomach, mam-
mary gland, and germ line. Therefore, the upstream 10-
kb enhancer may act in other germ layers outside the
neuroectoderm.
D5E2 showed activity in ESCs (5.1-fold) and had
higher activity in EBs(+RA) (16.7-fold) and in primary
neurospheres (18.2-fold), with the direction of NS/PCs,
while D2E showed the opposite pattern. We can recapi-
tulate the temporal regulation of CNS development in
vitro by using a neurosphere-based culture system of
ESC-derived NS/PCs [56]. D5E2 was continuously active
in secondary and tertiary neurospheres (TNS) (Addi-
tional file 4, Figure S4), indicating that transcription
through D5E2 was constantly active in NS/PCs in neural
development. To determine whether D5E2 functions bi-
directionally as an enhancer, we made a reporter gene
with a reverse-oriented D5E2 strand (Additional file 5,
Figure S5). The expression level with the reversed strand
decreased by half (0.56-fold vs. D5E2-P1 in NS/PCs), but
the reversed-oriented D5E2 was significantly still active.
This finding supports the identification of D5E2 as an
enhancer.
Using D5E2-P1 reporter gene, strong GFP(+) cell
populations were observed in GFAP(+) astrocytes or
Nestin(+) NS/PCs, and weak GFP(+) populations were
observed in bIII-Tubulin(+) neurons. Almost all GFP(+)
cells were Msi1(+). When comparing D5E2-P1 with
Msi1-ffLuc, the GFP(-) cell populations in the Nestin(+)
or GFAP(+) cells were slightly increased. This result
indicates that the D5E2-induced expression did not
represent all of the Msi1-ffLuc expression. Previous
observations showed that 10
-8M RA induces wide ranges
of regionalized cell populations in the brain–in the fore-
brain, midbrain, and hindbrain, but not in the spinal
cord [49]. In the present experiments, D5E2 was signifi-
cantly active in EBs (+RA), but regional specificity was
not clear, even though p300 binds to D5E2 both in the
forebrain and midbrain (52, 53). Transgenic mouse
assays with D5E2 will be necessary to resolve this
question.
We cannot exclude the possibility that other enhan-
cers activate Msi1 transcription after EB day 6, since we
screened active enhancer regions on EB day 6 by dele-
tion study of Msi1-BAC reporter gene. In addition, in
EB lysates that were analysed by Luciferase assay, small
cell populations were uncovered in which GFP was
expressed by other enhancers.
We searched for transcriptional factor binding sites in
D5E2 by in silico analysis, and found three well-con-
served SOX-binding sites (Additional file 6, Figure S6).
SOX family proteins are important for NSC maintenance
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Page 11 of 16[57,58], and transcribe the Nestin gene cooperatively with
POU family genes [39,59]. However, there is no highly
matched sequence with a POU-binding consensus in
D5E2. A SOX-binding site alone is not sufficient to exert
regulatory function; it requires a second site nearby to
bind a partner protein that will cooperate with the SOX
proteins [60]. Thus, SOX might act with other binding
partners if it functions at this enhancer site. Another can-
didate transcription factor is AP-2. We found four AP-2-
binding sites in D5E2. AP-2 is a retinoic acid-inducible
transcription factor that is expressed in the nervous sys-
tem and in neural crest cell lineages during murine devel-
opment [61,62]. AP-2 proteins can be viewed as
gatekeepers, controlling the balance between prolifera-
tion and differentiation during embyogenesis [63,64].
From these reports, the expression pattern and functional
properties of Msi1 could be relevant to those of AP-2.
Transcriptional analysis for a particular gene has
become more accessible through technical innovations
in genome information science. Genomic markers for
CpG islands, Histone methylation, and p300 ChIP-
sequences gave us information that was useful for iden-
tifying the enhancer regions. Our results from reporter
assays using deleted BACs or isolated enhancers agreed
well with this genetic marker information.
Our present data indicate that D5E2 is a useful tool
for identifying Msi1-expressing cells. Thus, transcrip-
tional analysis of D5E2 has the potential to accelerate
the elucidation of Msi1-mediated NS/PC and cancer
stem cell maintenance. Interestingly, Msi1 has been
reported as a marker for germinal cells in the intestine;
our Msi1-reporter mouse may be useful for studying
intestinal and other Msi1-expressing somatic stem cells
[27]. Furthermore, Msi1 is expressed in the bulge of the
hair follicles in which stem cells reside [30]. Interest-
ingly, Nestin positive cells also exist in the bulge and
the Nestin second intron-driven GFP positive/keratin 15
negative cells isolated from the bulge area can differenti-
ate into neurons and Schwann cells in vivo [65-68].
Thus, common transcription factors could be involved
in the expression of Msi1 and Nestin in the bulge area
cells and NS/PCs. This possibility should be demon-
strated in the future. Further analysis of Msi1-reporter
mouse and the identification of Msi1 enhancers in other
somatic stem cells may shed light on the regulation of
stem cell maintenance.
Conclusions
T h eD 5 E 2r e g i o no nt h es i x t hi n t r o no ft h eMsi1 gene
is one of the most effective Msi1 enhancers. This
enhancer region is especially active in NS/PCs and
astrocytes, in which there is marked endogenous Msi1
expression.
Methods
Generation of the Msi1-ffLuc BAC clone
The mouse genomic BAC clone RP24-132L16 was
obtained from the Children’sH o s p i t a lo fO a k l a n d
Research Institute (CHORI), and its derivatives were
used for Msi1 transcription reporter assays. To generate
the engineered BAC clone, ffLuc was combined with
300-bp regions homologous to the Msi1 gene at both
the 5’ and 3’ flanking ends of ffLuc. This DNA combina-
tion was constructed on the selection cassette vector
pL451, containing a neomycin-resistance gene with FRT
sites. The homologous recombination selection cassette
was linearized by SalI and PmeI digestion, gel-purified
(Qiagen), and transformed into E. Coli DH10B with
RP24-132L16 BAC DNA by standard electroporation
methods (Gene Pulser Xcell, Bio-Rad). Recombination
was performed with the Red ET system (Gene Bridges),
and the cells were then cultured on LB medium plates
containing chloramphenicol and kanamycin. Neo-resis-
tant clones were analyzed by junctional sequence to
identify correctly-targeted BACs. Through this proce-
dure, ffLuc was inserted at the Msi1 transcriptional start
site on the BAC DNA. The BAC DNA was purified
using a Large-Construct Kit (Qiagen).
Generation of the Msi1-ffLuc transgenic mouse
A Flp expression vector (706-Flp, Gene Bridges) was
transformed into the Msi1-ffLuc BAC containing DH10B
to remove the pGKp-neo-GHp(A) site (see general Gene
Bridges method). Replacement was confirmed by
sequencing and by kanamycin selection. DNA was line-
arized at a site within the vector with Pl-SceI, purified
by gel chromatography, and injected into the pronucleus
of fertilized mouse eggs. One expression line was estab-
lished on a C57BL/6 background.
Construction of D1-D5 BAC clones and minimized
enhancer reporter genes
The D1-D5 deletion cassettes were constructed on
pL452 using 300 bp of the homologous sites flanking
the deletion on each side. Deleted clones were identified
by kanamycin selection and by sequencing analysis of
both sides of the deletion site from the cassette inserted
into the BAC. Recombination was performed with a Red
ET system.
The primer sets used to generate the deletion cassettes
were as follows:
5’ homology site
D1-D4: (5’-BstXIGACAGGCACTGTGAGAACCAAC-
3’ and 5’-NotICTTTACTGTCCGTCTGTCCGTC-3’)
D5: (5’-BstXIGAAGGAGATCGTGGACTATGTGG-3’
and 5’-NotIGCAATCGGATCCGAAGTTCCTATAC-3’)
3’ homology site
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GAG-3’ and 5’-SalICCAGGAGCACTTGTCCAGAG-3’)
D2: (5’-EcoRIGAGGTCAAGGATGCTAACTGTGC-3’
and 5’-SalICTGAGCCTTGCTGTCTGGCTC-3’)
D3: (5’-EcoRIGTAGCTGCCTGAAGTCCTGCATC-
3’and 5’-SalIGAGACAGGGATCTCACTATGTAGC-3’)
D4: (5’-EcoRIGACTCTGGTACACATGGGAGACC-3’
and 5’-SalICACCACCGTCAGTGACCAC-3’)
D5: (5’-EcoRI GACAGGCACTGTGAGAACCAAC-3’
and 5’-SalICTTTACTGTCCGTCTGTCCGTC-3’)Mini-
mized enhancer reporter genes were constructed on
PGV-P2; SV40 promoter and Luciferase alignment were
replaced with an Msi1 promoter (P1) and ffLuc.
The primer sets used to generate D2E, D5E1, and
D5E2 were as follows:
D2E: (5’-CTGTGGGTTATCTTGGGGAAATCTTC-3’
and 5’-CCAGACAGCAAGGCTCAGG-3’)
D5E1: (5’-GACCAGATCTTAGGAGACCCTG-3’ and
5’-CAACCCCCTTATCAATCTTGGACG-3’)
D5E2: (5’-GATCTGGGTCCAAGACGCAG-3’ and 5’-
CTCCTGAGGCTGGCTGAG-3’)
Introduction of recombinant BAC into ESCs
All BAC DNAs were linearized at a site within the vec-
tor using Pl-SceI. DNA (20 μg) was electroporated into
2×1 0
6 undifferentiated ESCs (EB3 tg14 line) [69]. Elec-
troporation was performed in a Bio-Rad Gene Pulser set
at 0.25 kV and 300 μF using a 0.4 cm gap cuvette. Elec-
troporated cells were transferred to a 100-mm gelati-
nized dish containing 10 ml of GMEM medium (Sigma
G6148) supplemented with 10% FBS, glutamine (2 mM),
nonessential amino acids (0.1 mM), sodium pyruvate (1
mM), 2-mercaptoethanol (2-ME) (0.1 mM), sodium
bicarbonate (3 mM), HEPES (5 mM), and mLIF. Selec-
tion was done with 300 μg/ml neomycin. After eight
days of culture, colonies were picked up, transferred to
a 24-well gelatinized plate, and allowed to expand in a
complete medium.
Neural induction of ESCs
For embryoid body (EB) formation, ESCs were detached
and dissociated into single cells with 0.25% trypsin-
EDTA, and were then transferred onto a non-coated
bacteriological dish (Kord-Valmarkk) containing 10 ml
of aMEM (Gibco 11900-024) supplemented with 10%
FBS, sodium bicarbonate (3 mM), and 0.1 mM 2-ME
(EB medium) at a density of 5 × 10
4 cells/ml. After 2
days in floating culture, 10
-8 M all-transretinoic acid
(RA: Sigma R 2625) was added to the culture medium
and EBs were cultured for 4 days.
Neurosphere formation
EBs, including neural differentiated cells (NS/PCs), were
collected on day 6 and were allowed to settle to the
bottom of the tube for a few minutes. The collected EBs
were washed once with PBS and incubated with 0.25%
trypsin-EDTA for 5 min. The enzymatic reaction was
quenched by adding an equal volume of EB medium,
and the cells were dissociated with a transfer pipette by
triturating 30 times. The cells were then washed twice
with serum-free aMEM and resuspended in Media hor-
mone mix (MHM) medium, which contains DMEM/F-
12 (1:1) (Gibco 12100-046, 21700-075), glucose (0.6%),
glutamine (2 mM), sodium bicarbonate (3 mM), HEPES
(5 mM), insulin (25 Ag/ml), transferrin (100 Ag/ml),
progesterone (20 nM), sodium selenate (30 ng), and
putrescine (60 nM) (all from Sigma except for DMEM/
F-12). The dissociated EBs were cultured in MHM sup-
plemented with 20 ng/ml FGF and 20 ng/ml EGF for 6
days.
Neuronal and glial differentiation of neural stem cells
The dissociated secondary neurospheres were plated on
poly-l-ornithine/fibronectin-coated 10-mm cover glasses
at a cell density of 1.5 × 10
5 cells/0.75 cm
2 on a 48-well
culture plate and were allowed to differentiate for 4
days.
Luciferase assays
For transient plasmid transfection, mouse day-14.5
embryo telencephalons were dissected, and the disso-
ciated cells were cultured in MHM (+20 ng/ml FGF-2,
+20 ng/ml EGF) for 5 days. After some passages, 1 ×
10
5 cells were cultured for 2 days on 24-well culture
plates, after which they were transfected with plasmids
using GeneJuice (Novagen). After 2 days, the cells were
washed with PBS, cell lysis buffer (Toyo Ink) was added,
and the cells were incubated for 20 min at room tem-
perature. Luciferase substrate solution (25 μl) (Promega)
was added, and the luminescence was measured with a
Berthold Centro LB960 Luminometer. The assays were
internally calibrated with a standardized Renilla Lucifer-
ase solution to ensure uniformity between experiments.
For stable transgenic ESCs, CellTiter-Blue (Promega)
was used to count living cells for an internal control.
FACS sorting and qRT-PCR
EBs were dissociated with trypsin-EDTA, resuspended in
aMEM containing 10 mg/ml propidium iodide (PI), and
filtered (30 μm). Cell sorting and analyses were per-
formed using a FACS MoFlo flow cytometer/cell sorter
equipped with CELLQuest software (Becton-Dickinson).
Total RNA was isolated by the RNeasy Mini Kit (Qia-
gen) from cell fractions sorted according to GFP fluores-
cent intensity. Synthesis of cDNA was performed with
Superscript II RNase H reverse transcriptase (Invitrogen)
at 42°C for 50 min according to the manufacturer’s
instructions. Quantitative PCRs were performed with
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of different mRNAs, the amount of cDNA was normal-
ized to the level of ubiquitously expressed a-actin
mRNA. The primer sets used were as follows:
GFP: (5’- TGAACCGCATCGAGCTGAAGGG-3’ and
5’- TCCAGCAGGACCATGTGATCGC-3’),
Msi1: (5’-GGGATGGACGCCTTCATGCTG-3’ and 5’-
TGGCTTGGAACCCTGGGTAAC-3’),
Nestin: (5’-CTGAGAACTCTCGCTTGCAGACA-3’
and 5’- GGAAATGCAGCTTCAGCTTGG-3’).
Immunohistochemistry
Frozen sections (12 μm) of brains fixed with 4% parafor-
maldehyde were prepared using a cryostat (CM3000,
Leica). The sections were incubated with primary anti-
bodies in TNB blocking buffer (PerkinElmer) at 4°C
overnight, and then with fluorescent dye-conjugated sec-
ondary antibodies at room temperature for 1 hr. The
images were observed by fluorescence microscopy
(Axioplan2 Imaging, Carl Zeiss) and confocal laser scan-
ning microscopy (LSM700, Carl Zeiss). The following
antibodies were used: anti-Musashi1 (rat IgG) [9]
(1:500), anti-Nestin (mouse IgG, BD) (1:200), anti-GFAP
(rat IgG, Invitrogen) (1:200), anti-Group B1 SOX
[SOX1/(2)/3] (1:5000), and anti-GFP (chick IgG, Aves)
(1:500). Anti-Group B1 SOX [SOX1/(2)/3] antibody is
r e a c t i v et oS O X 1a n dS O X 3p r o t e i n s ,b u ti ta l s ow e a k l y
recognizes SOX2 protein [39].
Additional material
Additional file 1: Figure S1. GFP-expressing cells in the central
nervous system of adult Msi1-ffLuc transgenic mice. Anti-GFP and
anti-Msi1 immunoreactivities coincided well in the subgranular zone of
the hippocampus (A) and the subependimal zone of the lateral wall of
the lateral ventricle (B), where neurogenesis occurs. GFAP-positive neural
stem cells in the subependimal zone were also GFP-positive (C). GFAP-
positive astrocytes in the corpus callosum also showed GFP fluorescence
(D). Scale bar: 20 μm.
Additional file 2: Figure S2. Msi1-reporter GFP levels correlate with
endogenous Msi1 levels. Day-6 EBs(+RA) were dissociated, fixed, and
immunostained with anti-Msi1 and anti-GFP antibodies. The
immunofluorescence intensity was then analyzed by flow cytometry. Of
these cells, 80% were both GFP- and Msi1- positive (left panel). Right
panel shows the negative control stained with secondary antibodies
alone. The vertical axis shows FITC intensity; the horizontal axis shows PE
intensity.
Additional file 3: Figure S3. H3K4 methylation status of the Msi1
enhancer regions in ESCs and ESC-derived NS/PCs. ChIP-sequencing
data was gathered from the UCSC genome browser (Broad H3 ChIP-
sequence track). H3K4me1, known as an enhancer code for chromatin
modification, intensely marked the D5E1 and D5E2 enhancer sites in NS/
PCs. D3E was also H3K4me1-positive. D2E was strongly marked in ESCs
and was also marked in NS/PCs. These three sites are highly conserved
(see lower panel).
Additional file 4: Figure S4. D5E2 is an active enhancer in
secondary neurosphere and tertialry neurosphere. D5E2-P1 was
transcriptionally active in secondary neurospheres and tertiary
neurospheres. P1 alone was not active in either secondary neurospheres
or tertiary neurospheres.
Additional file 5: Figure S5. D5E2 functions bi-directionally as an
enhancer. A reverse-oriented D5E2-P1 strand linked with the ffLuc 3’ end
enhanced the transcriptional activity in ESCs and E14.5 NS/PCs [D5E2-P1
= 1 in each cell, D5E2 reverse-P1 = 0.4 1(ESCs), 0.56 (NS/PCs), P1 = 0.2 1
(ESCs), 0.12 (NS/PCs)]. The data represent the mean ±SEM of three
independent experiments. The data were subjected to non-repeated-
measures ANOVA tests, and p values were calculated by Bonferroni
multiple comparison tests. *p < 0.05: P1 to D5E2-P1, D5E2 reverse-P1.
Additional file 6: Figure S6. Candidate transcription-factor binding
sites in D5E2. Sequence comparisons of the Msi1 enhancer D5E2 sites
between human, dog, mouse and rat species; three potential SOX and
four potential AP-2 highly conserved binding sites were identified
(searched results are from the JASPAR CORE database).
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